Pharmacology and macrophage modulation of HPGDS inhibitor PK007 demonstrate reduced disease severity in DMD-affected muscles of the mdx mouse model.
Saved in:
| Title: | Pharmacology and macrophage modulation of HPGDS inhibitor PK007 demonstrate reduced disease severity in DMD-affected muscles of the mdx mouse model. |
|---|---|
| Authors: | Yarlagadda, Sai1,2 (AUTHOR) uqsyarla@uq.edu.au, Sheremeta, Chynna-Loren1,2 (AUTHOR), Cheung, Sang Won1 (AUTHOR), Cuffe, Alison1 (AUTHOR), Grounds, Miranda D.3 (AUTHOR) miranda.grounds@uwa.edu.au, Smythe, Mark L.2 (AUTHOR) m.smythe@imb.uq.edu.au, Noakes, Peter G.1 (AUTHOR) p.noakes@uq.edu.au |
| Source: | Skeletal Muscle. 4/24/2025, Vol. 15 Issue 1, p1-21. 21p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
